Clinical Trial Update: Studying Biomarkers in Patients With Pancreatic Cancer

View source ↗

Summary

The trial update reports the completion of a biomarker study in patients with pancreatic cancer conducted by Vanderbilt-Ingram Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Pancreatic Cancer | Status: COMPLETED